:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/lanacionpy/FFMSDEXB2VCPTGWUFGR45ZMAPI.jpeg)
Since last May 15, the World Health Organization (WHO) has reported notification of confirmed and suspected cases of monkeypox in non-endemic countries of the Americas Region (Australia, Belgium, Canada, France, Germany, Italy, Netherlands, Portugal, Spain, Sweden, UK, USA and Argentina).
In this regard, the Center for Public Health issued a recommendation for a diagnosis of monkeypox virus infection (simian pox) for laboratories in the country. In this way, the Ministry of Health shares accessible documents here and which is based on WHO interim guidelines on laboratory testing for monkeypox virus from 23 May 2022.
Read more: 1,988 confirmed cases of monkeypox were recorded in 35 countries worldwide
The aim is to provide guidance to laboratories on the detection of monkeypox virus, ensure timely identification of suspected cases, collection of samples, and implementation of molecular detection protocols, in national reference laboratories, according to existing capacities.
It details sampling and biosafety, sample types, storage, shipping, laboratory testing and waste management. They stressed that these guidelines will be updated according to the findings of the ongoing investigation.
Also read: Until July 1, Vaccination Campaigns Continue in Educational Institutions
“Internet trailblazer. Troublemaker. Passionate alcohol lover. Beer advocate. Zombie ninja.”
/cloudfront-us-east-1.images.arcpublishing.com/eluniverso/FTEC73B3HFHWHOUJFHJPCYHHY4.jpg)
:quality(85)/cloudfront-us-east-1.images.arcpublishing.com/infobae/3FBT6VVNRDO6XEXJQM5YMGSWSU.jpg)
